Skip to content

Factors Associated With Mortality in Streptococcal Anginosus Bacteremia

Factors Associated With Mortality in Streptococcal Anginosus Bacteremia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07343167
Acronym
SGA
Enrollment
400
Registered
2026-01-15
Start date
2025-09-08
Completion date
2027-03-08
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Streptococcal Infections

Keywords

Streptococcal Infections, Streptococcal Anginosus Bacteremia, Streptococcal anginosus infections

Brief summary

Streptococcal anginosus infections (S. constellatus, S. anginosus, and S. intermedius) are characterized by their severity, linked to high mortality and frequent infectious complications. Several studies in the literature highlight this severity, with mortality rates estimated at around 15%. The aim of this research is to identify the factors associated with mortality in Streptococcal anginosus bacteremia.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major subject (≥18 years old) * Hospitalized between January 1, 2019, and December 31, 2024, in one of the participating centers * Having presented during the study period at least one positive blood culture for Streptococcus anginosus, Streptococcus constellatus, or Streptococcus intermedius in a laboratory at a participating center

Exclusion criteria

* Refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
28-day in-hospital mortality28-Day Mortality Following Streptococcal Infection28-Day In-Hospital Mortality Following Streptococcal Infection

Countries

France

Contacts

Primary ContactVictor GERBER, MD
victor.gerber@chru-strasbourg.fr33 3 68 85 37 97

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026